Fresenius looking at HY bonds, loans to fund Rhön-Klinikum acquisition
German healthcare company Fresenius has arranged an underwritten loan facility that will, alongside a high yield bond and an equity piece of up to €1bn, finance its €3.1bn planned acquisition of all outstanding shares in Rhön-Klinikum.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
